These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1404961)

  • 21. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Free L-fucose (UFC) and sulfated bile acids in urine (U-SBA)].
    Mashige F
    Nihon Rinsho; 1999 Dec; 57 Suppl():597-601. PubMed ID: 10778201
    [No Abstract]   [Full Text] [Related]  

  • 23. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
    Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
    Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of urinary pseudouridine as a tumor marker in lung cancer.
    Lu JY; Lai RS; Liang LL; Wang HC; Lin TI
    J Formos Med Assoc; 1994 Jan; 93(1):25-9. PubMed ID: 7915576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H; Kaya M; Cengiz A
    Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of novel tumour markers.
    Rhodes JM
    Ann Oncol; 1999; 10 Suppl 4():118-21. PubMed ID: 10436801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study.
    Liska V; Treska V; Skalicky T; Fichtl J; Bruha J; Vycital O; Topolcan O; Palek R; Rosendorf J; Polivka J; Holubec L
    Anticancer Res; 2017 Apr; 37(4):2003-2009. PubMed ID: 28373474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical value of urinary polyamine analysis in urological disease].
    Matsuda M; Seguchi T; Sugao H; Nakano E; Okuyama A; Sonoda T
    Hinyokika Kiyo; 1988 Oct; 34(10):1703-10. PubMed ID: 3245519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
    Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
    Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical investigation of carbohydrate antigen CA-50].
    Ishii M; Abe O; Okura H; Okazaki N; Kawai T; Saito Y; Sawabu N; Takamizawa Y; Takeuchi T; Niitani H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine interleukin-8 as a marker of vesicoureteral reflux in infants.
    Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M
    Pediatrics; 2006 May; 117(5):e863-7. PubMed ID: 16585276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum APRIL, a potential tumor marker in pancreatic cancer.
    Wang F; Chen L; Ding W; Wang G; Wu Y; Wang J; Luo L; Cong H; Wang Y; Ju S; Shao J; Wang H
    Clin Chem Lab Med; 2011 Oct; 49(10):1715-9. PubMed ID: 21612541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery.
    Che M; Xie B; Xue S; Dai H; Qian J; Ni Z; Axelsson J; Yan Y
    Nephron Clin Pract; 2010; 115(1):c66-72. PubMed ID: 20173352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.
    Ritchie SA; Chitou B; Zheng Q; Jayasinghe D; Jin W; Mochizuki A; Goodenowe DB
    World J Gastroenterol; 2015 Jun; 21(21):6604-12. PubMed ID: 26074698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G; Teli M; Jardine N; Puntis MC
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
    JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of CA19-9 in diagnosis of digestive tract tumors.
    Zhao JZ; Wu BH
    World J Gastroenterol; 1997 Dec; 3(4):253-4. PubMed ID: 27053885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.